Source comparison
The Regulatory Status of Melanotan-1 vs Scenesse
Melanotan-1 fda approved status depends entirely on formulation and indication. The confusion stems from one narrow FDA approval: Scenesse (afamelanotide 16mg implant), approved in 2019 for adult patients with erythropoietic protoporphyria (EPP). Scenesse is a
This comparison does not assign a generated winner or score.
- Melanotan-1 fda approved status depends entirely on formulation and indication. The confusion stems from one narrow FDA approval: Scenesse (afamelanotide 16mg implant), approved in 2019 for adult patients with erythropoietic protoporphyria (EPP). Scenesse is a biodegradable subcutaneous implant that releases afamelanotide. The synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH). Over 60 days. It is not available by prescription for tanning, cosmetic darkening, or general photoprotection. The FDA approval is disease-specific, and the implant cannot be compounded, sold as an injectable, or prescribed off-label for cosmetic indications.
- Every other form of Melanotan-1. Lyophilised powder sold online, reconstituted vials marketed as 'research peptides,' or pre-mixed injectables. Falls outside FDA oversight entirely. These products are neither approved drugs nor regulated dietary supplements. The FDA classifies them as unapproved new drugs under 21 USC §355, meaning their sale for human consumption violates federal law. The Melanotan-1 fda approved status for injectable forms is unambiguous: there is none. Vendors circumvent enforcement by labelling products 'for research purposes only' and disclaiming human use, but that label holds no legal weight once the product is marketed with dosing instructions, tanning protocols, or before-and-after photos.
- The biological mechanism is identical across formulations. Afamelanotide binds to melanocortin-1 receptors (MC1R) on melanocytes, triggering eumelanin synthesis independent of UV exposure. But regulatory approval hinges on manufacturing standards, dosage consistency, sterility verification, and clinical trial evidence. Scenesse meets those requirements for EPP treatment. Online Melanotan-1 does not meet them for any use.